Oncogenic stress induced by acute hyper-activation of Bcr-Abl leads to cell death upon induction of excessive aerobic glycolysis.
In response to deregulated oncogene activation, mammalian cells activate disposal programs such as programmed cell death. To investigate the mechanisms behind this oncogenic stress response we used Bcr-Abl over-expressing cells cultivated in presence of imatinib. Imatinib deprivation led to rapid in...
Enregistré dans:
Auteurs principaux: | Michael A Dengler, Annette M Staiger, Matthias Gutekunst, Ute Hofmann, Malgorzata Doszczak, Peter Scheurich, Matthias Schwab, Walter E Aulitzky, Heiko van der Kuip |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/30003634020a4e90af9989fc1b2c9212 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase
par: Sina Reckel, et autres
Publié: (2017) -
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias
par: Oksana Montecchini, et autres
Publié: (2021) -
Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended.
par: Sarah Huet, et autres
Publié: (2014) -
Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
par: Amin Huma, et autres
Publié: (2021) -
Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
par: Diletta Fontana, et autres
Publié: (2021)